Published in J Ophthalmol on August 14, 2014
Sex differences in the effect of aging on dry eye disease. Clin Interv Aging (2017) 0.87
Results of a Multicenter, Randomized, Double-Masked, Placebo-Controlled Clinical Study of the Efficacy and Safety of Visomitin Eye Drops in Patients with Dry Eye Syndrome. Adv Ther (2015) 0.79
Ocular Surface and Tear Film Changes in Older Women Working with Computers. Biomed Res Int (2015) 0.78
Ocular Toxicity of Tyrosine Kinase Inhibitors. Oncol Nurs Forum (2016) 0.75
Cutaneous and Mucosal Manifestations of Sjögren's Syndrome. Clin Rev Allergy Immunol (2017) 0.75
Number of people with glaucoma worldwide. Br J Ophthalmol (1996) 14.31
The epidemiology of dry eye disease: report of the Epidemiology Subcommittee of the International Dry Eye WorkShop (2007). Ocul Surf (2007) 5.62
Incidence of Parkinson's disease: variation by age, gender, and race/ethnicity. Am J Epidemiol (2003) 5.00
Prevalence of dry eye syndrome among US women. Am J Ophthalmol (2003) 4.46
Impact of dry eye syndrome on vision-related quality of life. Am J Ophthalmol (2007) 3.96
Prevalence of and risk factors for dry eye syndrome. Arch Ophthalmol (2000) 3.94
Age-related changes in pharmacokinetics and pharmacodynamics: basic principles and practical applications. Br J Clin Pharmacol (2004) 3.23
Treatment of dry eye by autologous serum application in Sjögren's syndrome. Br J Ophthalmol (1999) 2.77
Two multicenter, randomized studies of the efficacy and safety of cyclosporine ophthalmic emulsion in moderate to severe dry eye disease. CsA Phase 3 Study Group. Ophthalmology (2000) 2.74
Preservatives in eyedrops: the good, the bad and the ugly. Prog Retin Eye Res (2010) 2.68
Prevalence of dry eye disease among US men: estimates from the Physicians' Health Studies. Arch Ophthalmol (2009) 2.65
Prevalence of ocular surface disease in glaucoma patients. J Glaucoma (2008) 2.65
Visual impairment and falls in older adults: the Blue Mountains Eye Study. J Am Geriatr Soc (1998) 2.51
Performance-based and self-assessed measures of visual function as related to history of falls, hip fractures, and measured gait time. The Beaver Dam Eye Study. Ophthalmology (1998) 2.50
Tear cytokine profiles in dysfunctional tear syndrome. Am J Ophthalmol (2008) 2.37
Conjunctivochalasis: literature review and possible pathophysiology. Surv Ophthalmol (1999) 2.28
Prescription drug use continues to increase: U.S. prescription drug data for 2007-2008. NCHS Data Brief (2010) 2.21
Dry eye-induced conjunctival epithelial squamous metaplasia is modulated by interferon-gamma. Invest Ophthalmol Vis Sci (2007) 2.09
Impaired vision and hip fracture. The Framingham Study. J Am Geriatr Soc (1989) 1.97
Analysis of inflammatory cytokines in the tears of dry eye patients. Cornea (2009) 1.96
Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging. J Clin Endocrinol Metab (1997) 1.96
Tear film osmolarity: determination of a referent for dry eye diagnosis. Invest Ophthalmol Vis Sci (2006) 1.82
Mechanisms of action of cyclosporine. Immunopharmacology (2000) 1.81
The relative burden of dry eye in patients' lives: comparisons to a U.S. normative sample. Invest Ophthalmol Vis Sci (2005) 1.75
Prevalence of ocular surface complaints in patients with glaucoma using topical intraocular pressure-lowering medications. Cornea (2010) 1.65
Foreshortening of the inferior conjunctival fornix associated with chronic glaucoma medications. Ophthalmology (1992) 1.58
An in vivo confocal masked study on corneal epithelium and subbasal nerves in patients with dry eye. Invest Ophthalmol Vis Sci (2004) 1.51
Long-term incidence of dry eye in an older population. Optom Vis Sci (2008) 1.51
Meibomian gland dysfunction. Surv Ophthalmol (1996) 1.46
Corneal innervation and morphology in primary Sjögren's syndrome. Invest Ophthalmol Vis Sci (2003) 1.41
A randomized, double-masked, placebo-controlled, multicenter comparison of loteprednol etabonate ophthalmic suspension, 0.5%, and placebo for treatment of keratoconjunctivitis sicca in patients with delayed tear clearance. Am J Ophthalmol (2004) 1.39
Alterations in corneal sensitivity and nerve morphology in patients with primary Sjögren's syndrome. Exp Eye Res (2008) 1.36
The economic burden of dry eye disease in the United States: a decision tree analysis. Cornea (2011) 1.32
Utility assessment to measure the impact of dry eye disease. Ocul Surf (2006) 1.27
Involvement of oxidative stress on corneal epithelial alterations in a blink-suppressed dry eye. Invest Ophthalmol Vis Sci (2007) 1.24
Decreased corneal sensitivity in patients with dry eye. Invest Ophthalmol Vis Sci (2005) 1.23
Pilocarpine tablets for the treatment of dry mouth and dry eye symptoms in patients with Sjögren syndrome: a randomized, placebo-controlled, fixed-dose, multicenter trial. P92-01 Study Group. Arch Intern Med (1999) 1.23
Corneal epitheliopathy of dry eye induces hyperesthesia to mechanical air jet stimulation. Am J Ophthalmol (2004) 1.20
Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol (2011) 1.18
Inflammatory cytokines in the tears of patients with ocular rosacea. Ophthalmology (1997) 1.17
The effects of different hormone replacement therapy regimens on tear function, intraocular pressure and lens opacity. Gynecol Endocrinol (2006) 1.14
A double-blind, randomized, placebo-controlled study of cevimeline in Sjögren's syndrome patients with xerostomia and keratoconjunctivitis sicca. Arthritis Rheum (2002) 1.14
Dry eye in the beaver dam offspring study: prevalence, risk factors, and health-related quality of life. Am J Ophthalmol (2014) 1.12
Corneal nerve structure and function in patients with non-sjogren dry eye: clinical correlations. Invest Ophthalmol Vis Sci (2013) 1.09
Smoking associated with damage to the lipid layer of the ocular surface. Am J Ophthalmol (2006) 1.08
Interferon-γ exacerbates dry eye-induced apoptosis in conjunctiva through dual apoptotic pathways. Invest Ophthalmol Vis Sci (2011) 1.08
Do sex steroids exert sex-specific and/or opposite effects on gene expression in lacrimal and meibomian glands? Mol Vis (2009) 1.06
Impact of symptomatic dry eye on vision-related daily activities: the Singapore Malay Eye Study. Eye (Lond) (2010) 1.06
Inflamm-aging does not simply reflect increases in pro-inflammatory markers. Mech Ageing Dev (2014) 1.03
Structure and biological roles of mucin-type O-glycans at the ocular surface. Ocul Surf (2010) 1.01
Age-related modifications of corneal sensitivity. Ophthalmologica (2004) 0.97
The relationship between subbasal nerve morphology and corneal sensation in ocular surface disease. Invest Ophthalmol Vis Sci (2012) 0.96
Conjunctival inflammation in thrombospondin-1 deficient mouse model of Sjögren's syndrome. PLoS One (2013) 0.95
Predictors of falls in the Melbourne visual impairment project. Aust N Z J Public Health (2002) 0.95
Estrogen's and progesterone's impact on gene expression in the mouse lacrimal gland. Invest Ophthalmol Vis Sci (2006) 0.94
Involutional entropion and ectropion of the lower eyelid: prevalence and associated risk factors in the elderly population. Ophthal Plast Reconstr Surg (2011) 0.94
Changes of conjunctivochalasis with age in a hospital-based study. Am J Ophthalmol (2008) 0.94
Modulation of conjunctival goblet cell function by inflammatory cytokines. Mediators Inflamm (2013) 0.92
Upper punctal occlusion versus lower punctal occlusion in dry eye. Invest Ophthalmol Vis Sci (2010) 0.92
Corneal sensitivity, blink rate, and corneal nerve density in progressive supranuclear palsy and Parkinson disease. Cornea (2013) 0.91
Visual acuity and the ability of the visually impaired to read medication instructions. Br J Ophthalmol (2004) 0.90
The aging Meibomian gland: an in vivo confocal study. Invest Ophthalmol Vis Sci (2013) 0.89
Improving awareness, identification, and management of meibomian gland dysfunction. Ophthalmology (2012) 0.89
Hormones and dry eye syndrome: an update on what we do and don't know. Curr Opin Ophthalmol (2013) 0.88
Oxidative stress and its downstream signaling in aging eyes. Clin Interv Aging (2014) 0.85
Age-related changes of human conjunctiva on in vivo confocal microscopy. Br J Ophthalmol (2010) 0.83
Effects of phytoestrogen supplementation in postmenopausal women with dry eye syndrome: a randomized clinical trial. Can J Ophthalmol (2012) 0.83
Androgen deficiency and dry eye syndrome in the aging male. Invest Ophthalmol Vis Sci (2014) 0.82
The role of medications in causing dry eye. J Ophthalmol (2012) 0.81
The anatomy of the lacrimal portion of the orbicularis oculi muscle (tensor tarsi or Horner's muscle). Okajimas Folia Anat Jpn (2001) 0.81
Transdermal androgen patches in evaporative dry eye syndrome with androgen deficiency: a pilot study. Br J Ophthalmol (2013) 0.81
Conjunctivochalasis. Can J Ophthalmol (1996) 0.80
[Dry eye disease in patients treated with antidepressants]. Klin Oczna (2013) 0.80
Noninvasive assessment of corneal sensitivity in young and elderly diabetic and nondiabetic subjects. Invest Ophthalmol Vis Sci (2004) 0.79
Age-related differential expression of apoptosis-related genes in conjunctival epithelial cells. Acta Ophthalmol Scand (2005) 0.79
Amiloride disposition in geriatric patients: importance of renal function. Br J Clin Pharmacol (1990) 0.78
[Hormonal regulatory influence in tear film]. J Fr Ophtalmol (2004) 0.78
Mental wellbeing and quality of sexual life in women with primary Sjögren's syndrome are related to circulating dehydroepiandrosterone sulphate. Ann Rheum Dis (2003) 0.77
[Ocular surface in glaucoma patients with topical treatment]. Oftalmologia (2011) 0.76